Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 8.79%3.94B | 13.72%1.02B | 5.25%1B | 1.94%1.1B | 18.00%811.5M | 13.42%3.62B | 10.95%898.7M | 16.69%953.1M | 25.76%1.08B | -2.54%687.7M |
Net income from continuing operations | 18.08%2.04B | 16.66%512.5M | 17.82%565.9M | 19.74%511.9M | 18.18%453.7M | 16.33%1.73B | 26.45%439.3M | 15.21%480.3M | 14.98%427.5M | 9.09%383.9M |
Operating gains losses | 155.91%238M | 17.58%113.7M | 4,421.05%82.1M | 1,100.00%33.6M | 286.96%8.6M | -40.76%93M | 0.94%96.7M | -104.05%-1.9M | -77.05%2.8M | -319.05%-4.6M |
Depreciation and amortization | 11.57%1.78B | 10.15%469.7M | 10.25%448.7M | 14.89%439.8M | 11.23%425.8M | 10.96%1.6B | 14.53%426.4M | 8.04%407M | 6.36%382.8M | 15.27%382.8M |
Deferred tax | -14.71%87M | -66.27%16.8M | 20.74%22.7M | --0 | 227.59%47.5M | -43.65%102M | -38.37%49.8M | -60.34%18.8M | -32.26%18.9M | -41.77%14.5M |
Other non cash items | 0.00%-26M | 41.12%-12.6M | -363.27%-22.7M | 227.08%6.1M | -37.25%3.2M | 42.22%-26M | 39.38%-21.4M | 66.44%-4.9M | -2,300.00%-4.8M | 0.00%5.1M |
Change In working capital | -1,140.00%-260M | 16.93%-96.2M | -517.89%-102.8M | -63.07%84.8M | -28.57%-145.8M | 122.32%25M | -59.94%-115.8M | 132.07%24.6M | 244.74%229.6M | -284.41%-113.4M |
-Change in receivables | -7.04%-76M | -73.44%23.9M | 72.02%-30.5M | -40.25%-68.3M | 66.67%-1.1M | 64.32%-71M | 1,167.61%90M | -95.69%-109M | 56.52%-48.7M | 91.41%-3.3M |
-Change in prepaid assets | -470.00%-171M | 26.35%-111.5M | -459.65%-95.7M | -64.72%18.1M | -79.24%18.1M | 64.29%-30M | -35.18%-151.4M | 61.66%-17.1M | 188.20%51.3M | 59.12%87.2M |
-Change in payables and accrued expense | -132.53%-27M | 93.33%-700K | -178.42%-45.8M | -80.51%20.7M | 98.31%-1.2M | -21.70%83M | -226.51%-10.5M | 184.15%58.4M | 12.86%106.2M | -197.40%-71.1M |
-Change in other current liabilities | -67.44%14M | 82.00%-7.9M | -25.03%69.2M | -5.38%114.3M | -28.05%-161.6M | -33.85%43M | -281.40%-43.9M | -0.75%92.3M | 81.11%120.8M | -6.14%-126.2M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 8.79%3.94B | 13.72%1.02B | 5.25%1B | 1.94%1.1B | 18.00%811.5M | 13.42%3.62B | 10.95%898.7M | 16.69%953.1M | 25.76%1.08B | -2.54%687.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 30.16%-2.56B | 48.12%-812.5M | -49.07%-635.8M | 57.51%-433.8M | -3.92%-678.9M | 17.09%-3.67B | -116.90%-1.57B | -2.28%-426.5M | 64.60%-1.02B | -63.57%-653.3M |
Net PPE purchase and sale | -12.86%-1.81B | 15.56%-459.2M | -20.83%-436.2M | -23.38%-400.5M | -37.44%-512.1M | -12.74%-1.6B | -4.54%-543.8M | -31.99%-361M | -4.71%-324.6M | -17.43%-372.6M |
Net business purchase and sale | 63.53%-751M | 65.03%-353.1M | -223.45%-198.6M | 95.26%-33M | 42.97%-166.3M | 31.09%-2.06B | -429.97%-1.01B | 56.91%-61.4M | 72.94%-696.4M | -257.35%-291.6M |
Net other investing changes | 66.67%-2M | 98.44%-200K | 75.61%-1M | ---300K | -104.59%-500K | 57.14%-6M | -12.28%-12.8M | -310.00%-4.1M | --0 | 2,280.00%10.9M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 30.16%-2.56B | 48.12%-812.5M | -49.07%-635.8M | 57.51%-433.8M | -3.92%-678.9M | 17.09%-3.67B | -116.90%-1.57B | -2.28%-426.5M | 64.60%-1.02B | -63.57%-653.3M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -2,354.84%-1.4B | -132.74%-209.9M | -38.13%-753.5M | -2,912.05%-233.4M | -379.05%-201.2M | -95.39%62M | 2,988.29%641.2M | -26.07%-545.5M | -99.61%8.3M | 86.65%-42M |
Net issuance payments of debt | -120.37%-200M | -85.25%130.2M | -115.95%-429.3M | -38.74%103.1M | -103.09%-4M | -54.62%982M | 532.45%882.9M | 30.88%-198.8M | -92.57%168.3M | 170.00%129.6M |
Net common stock issuance | -88.59%-496M | -130.60%-157.5M | 20.14%-149.9M | -4,182.50%-163.3M | -130.00%-25.3M | -21.76%-263M | -17,175.00%-68.3M | -7,319.23%-187.7M | 200.00%4M | 94.88%-11M |
Cash dividends paid | -7.68%-687M | -8.13%-182.2M | -7.35%-168M | -7.60%-168.5M | -7.61%-168.3M | -7.59%-638M | -7.67%-168.5M | -7.71%-156.5M | -7.78%-156.6M | -7.20%-156.4M |
Net other financing activities | 21.05%-15M | 91.84%-400K | -152.00%-6.3M | 36.49%-4.7M | 14.29%-3.6M | -72.73%-19M | 14.04%-4.9M | -4.17%-2.5M | -572.73%-7.4M | -133.33%-4.2M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -2,354.84%-1.4B | -132.74%-209.9M | -38.13%-753.5M | -2,912.05%-233.4M | -379.05%-201.2M | -95.39%62M | 2,988.29%641.2M | -26.07%-545.5M | -99.61%8.3M | 86.65%-42M |
Net cash flow | ||||||||||
Beginning cash position | 6.54%228M | -18.83%206M | 116.78%591.8M | -23.37%158.4M | 6.16%227.5M | 101.89%214M | 71.72%253.8M | 48.61%273M | 112.87%206.7M | 102.94%214.3M |
Current changes in cash | -276.92%-23M | 98.48%-400K | -1,943.39%-386.2M | 556.84%432.2M | -802.63%-68.6M | -88.29%13M | -140.03%-26.3M | 42.55%-18.9M | -24.11%65.8M | 10.59%-7.6M |
Effect of exchange rate changes | -300.00%-2M | -487.50%-3.1M | 233.33%400K | 140.00%1.2M | ---500K | 133.33%1M | 700.00%800K | 90.00%-300K | 600.00%500K | --0 |
End cash Position | -10.96%203M | -10.96%203M | -18.83%206M | 116.78%591.8M | -23.37%158.4M | 6.54%228M | 6.54%228M | 71.72%253.8M | 48.61%273M | 112.87%206.7M |
Free cash flow | 4.73%2.08B | 49.44%524.4M | -3.53%563.6M | -6.30%696M | -3.91%297M | 14.46%1.99B | 24.96%350.9M | 8.33%584.2M | 36.44%742.8M | -16.80%309.1M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |